IC
KURA icon

IEQ Capital’s Kura Oncology KURA Stock Holding History

IEQ Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Buy
348,125
+66,221
+23% +$625K 0.02% 584
2026
Q1 		$2.29M Sell
281,904
-116,551
-29% -$1M 0.01% 720
2025
Q4 		$4.14M Buy
398,455
+124,369
+45% +$1.3M 0.01% 572
2025
Q3 		$2.43M Buy
274,086
+131,279
+92% +$936K 0.01% 697
2025
Q2 		$824K Buy
142,807
+44,876
+46% +$275K 0.01% 927
2025
Q1 		$646K Buy
+97,931
New +$763K 0.01% 882

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

IEQ Capital's KURA Position: Q2 2026 in Review

IEQ Capital increased its Kura Oncology (KURA) stake by 23% in Q2 2026, buying an estimated $625K and bringing the position to 348,125 shares worth $3.82M. The position accounts for 0.02% of the portfolio, ranked #584.

IEQ Capital first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.14M in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • IEQ Capital held 348,125 shares of Kura Oncology worth $3.82M as of Q2 2026.
  • IEQ Capital bought 66,221 Kura Oncology shares in Q2 2026, an estimated $625K.
  • Kura Oncology made up 0.02% of IEQ Capital's portfolio in Q2 2026, its #584 holding.
  • IEQ Capital first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Kura Oncology position peaked at $4.14M in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.